MODERATOR
:
SPEAKER
(S):
Sharon O'Callaghan, MT(ASCP), Consumer Safety Officer, FDA/CBER
Mrs. Lisa Phillips Johnson, MT(ASCP)SBB, CQA, CMQ/OE, RAC, Quality and Regulatory Affairs Director, Cleveland Cord Blood Center
Description
Reporting of events to regulatory agencies is an intimidating task. A recent article in the Journal of Blood Services Management, illustrated the common misconceptions of when and what to report to the FDA. This session will introduce scenarios to assess knowledge before and after the session. We will cover the five W's of event reporting Who, What, When, Where and Why. The scenarios will cover all aspects of cellular therapy IND and BLA products, apheresis, NMDP and international units.
-
Determine how to report, when to report and who is responsible for reporting these events.
-
Explain the rationale behind the HCT/P Deviation reportable events.
-
Identify which events are reportable to the FDA or other agencies and which are not.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.